Company: EUDAW
Filing Date: 2025-08-08
Form Type: 424B5
Source: 0001493152-25-011729
Chunk: 18

Company: EUDA Health Holdings Ltd
Filing Date: 2025-08-08
Form: 424B5
Chunk 18
---
     |   |      |
| As adjusted                                           
 net tangible book value per share after this offering |     |       |   |     |   | 0.11 |
| Dilution in net tangible                              
 book value per share to new investors                 |     |       |   |     | $ | 2.30 |

The following table illustrates this calculation on a per share basis:

The
table above assumes for illustrative purposes only an aggregate of 4,149,378 shares of our ordinary shares are sold at a price
of $2.41 per share, for aggregate gross proceeds of $10.0 million. An increase of $1.00 per share in the price at which the shares
are sold from the assumed offering price per share shown in the table above, or $3.41 per share, assuming all of our ordinary
shares in the aggregate amount of $10.0 million is sold at that price, would increase our adjusted net tangible book value per share
after the offering to $0.11 per share and would increase the dilution in net tangible book value per share to new investors in
this offering to $0.19 per share, after deducting commissions and estimated aggregate offering expenses payable by us. A decrease
of $1.00 per share in the price at which the shares are sold from the assumed offering price per share shown in the table above, or $1.41
per share, assuming all of our ordinary shares in the aggregate amount of $10.0 million is sold at that price, would increase our adjusted
net tangible book value per share after the offering to $0.10 per share and would decrease the dilution in net tangible book value
per share to new investors in this offering to $0.18 per share, after deducting commissions and estimated aggregate offering expenses
payable by us. This information is supplied for illustrative purposes only.

The
calculations above are based on 37,156,382 ordinary shares issued and outstanding as of August 7, 2025, exclude the following:

| ● | 37,516                                                                                                                               
 of our ordinary shares issuable upon conversion of convertible notes in the aggregate principal amount of $53,402 as of June 23,     
 2025 at a weighted-average exercise price of $1.42 per share.                                                                        |
| ● | 4,458,625                                                                                                                            
 of our ordinary shares issuable upon exercise of an aggregate of 8,917,250 outstanding warrants